spleen tyrosine kinase
Showing 1 - 25 of 4,215
Advanced Malignant Solid Tumor, KRAS Gene Mutation, Ovarian Carcinoma Trial in Houston (Paclitaxel, Pharmacokinetic Study,
Active, not recruiting
- Advanced Malignant Solid Neoplasm
- +4 more
- Paclitaxel
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Dec 13, 2021
Renal Transplant Rejection Trial in London (Fostamatinib)
Recruiting
- Renal Transplant Rejection
-
London, United KingdomImperial College NHS Healthcare Trust
Oct 1, 2021
DLBCL, DLBCL Activated B-Cell Type, DLBCL Germinal Center B-Cell Type Trial in Chicago (Cyclophosphamide, Doxorubicin
Active, not recruiting
- Diffuse Large B-Cell Lymphoma
- +6 more
- Cyclophosphamide
- +5 more
-
Chicago, IllinoisNorthwestern University
Apr 30, 2021
Tumor Feeding Vessels Deprivation Combined With Tyrosine Kinase
Recruiting
- Liver Transplant
- PVHA or TACE
-
Shanghai, Shanghai, ChinaThe value of tumor feeding vessels deprivation combined with tyr
Nov 26, 2022
Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)
Not yet recruiting
- Tyrosine Kinase Inhibitors
- Chronic Myeloid Leukemia
- treatment of TKI in CML
-
Poitiers, FranceChu Poitiers
Feb 21, 2023
Liver Tumors Trial in Beijing (Tislelizumab plus tyrosine kinase inhibitor)
Recruiting
- Liver Neoplasms
- Tislelizumab plus tyrosine kinase inhibitor
-
Beijing, Beijing, China302 Hospital
Sep 22, 2023
CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)
Recruiting
- CML
- Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
-
Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, ArgentinaFUNDALEU
Jun 29, 2023
Eosinophilic Myeloid Tumor, Hypereosinophilic Syndrome Trial run by the National Institute of Allergy and Infectious Diseases
Recruiting
- Eosinophilic Myeloid Neoplasm
- Hypereosinophilic Syndrome
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Lung Cancer, Non Small Cell Lung Cancer Trial in Aurora (Amivantamab 1050mg, Amivantamab 1400mg, Amivantamab (to be determined))
Not yet recruiting
- Lung Cancer
- Non Small Cell Lung Cancer
- Amivantamab 1050mg
- +2 more
-
Aurora, Colorado
- +2 more
Apr 25, 2023
Acute Lymphoblastic Leukemia Trial in Ann Arbor (Dasatinib, Ponatinib, Berlin-Frankfurt-Münster Chemotherapy)
Recruiting
- Acute Lymphoblastic Leukemia
- Dasatinib
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Nov 28, 2022
Breast Cancer Trial in Guangzhou (Take probiotics)
Recruiting
- Breast Cancer
- Take probiotics
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Mar 6, 2023
Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam
Recruiting
- Non Small Cell Lung Cancer
- +2 more
-
Rotterdam, NetherlandsErasmus MC
Feb 2, 2022
Gastrointestinal Stromal Tumors (GISTs) Trial in Seoul (Imatinib Mesylate)
Completed
- Gastrointestinal Stromal Tumors (GISTs)
- Imatinib Mesylate
-
Seoul, Korea, Republic ofAsan Medical Center
Dec 30, 2022
B-cell Malignancies Undergoing Treatment With Bruton Tyrosine
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +4 more
- Non-Interventional Study
-
Rochester, MinnesotaMayo Clinic in Rochester
Nov 22, 2023
Atrial Fibrillation, Supraventricular Arrhythmia, Ventricular Arrhythmias and Cardiac Arrest Trial in New Hyde Park (Medtronic
Recruiting
- Atrial Fibrillation
- +4 more
- Medtronic LINQ-2 Insertable Cardiac Monitor (ILR)
-
New Hyde Park, New YorkNorthwell (Northshore University/Long Island Jewish Hospitals)
Dec 1, 2022
Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (tolebrutinib 60mg,
Active, not recruiting
- Multiple Sclerosis
- tolebrutinib 60mg
- tolebrutinib 120mg
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Australia, Poland (TG-1701, Umbralisib, Ublituximab)
Active, not recruiting
- Non Hodgkin Lymphoma
- Chronic Lymphocytic Leukemia
- TG-1701
- +2 more
-
East Melbourne, Victoria, Australia
- +7 more
Jan 20, 2023
Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes
Active, not recruiting
- Patients Diagnosed as Chronic Meyloid Leukemia
- Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
-
Assiut, EgyptAssiut University Hospital
Feb 19, 2022
Non Small Cell Lung Cancer Trial in Mexico City (Metformin Hydrochloride, Placebo)
Recruiting
- Non Small Cell Lung Cancer
- Metformin Hydrochloride
- Placebo
-
Mexico City, MexicoInstituto Nacional de Cancerologia
Jul 21, 2022
Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)
Recruiting
- Olverembatinib
- +2 more
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital
Jul 26, 2022
Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia
Not yet recruiting
- Tyrosine Kinase Inhibitor
- +2 more
-
Taipei, TaiwanNational Taiwan University Hospital
Feb 17, 2022
Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Positive Trial in New York (Blinatumomab, dasatinib, dexamethasone)
Recruiting
- Acute Lymphoblastic Leukemia
- Philadelphia Chromosome-Positive
- Blinatumomab
- +3 more
-
New York, New York
- +1 more
Nov 10, 2022
r/r B-cell Lymphoma Intolerant to Other Bruton Tyrosine Kinase
Not yet recruiting
- B-cell Lymphoma
-
Beijing, Beijing, ChinaDeparment of Hematology, Peking University People's Hospital
Aug 9, 2022
Tyrosine Kinase Inhibitors in Trastuzumab Emtansine Resistant
Recruiting
- Breast Cancer
-
Nanjing, Jiangsu, ChinaJiangsu Provincial People's Hospital
Feb 7, 2022